OpenAlex
PricingAboutJobs
Log inGet started
Work

A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2

HTML

Year: 2013
Type: article
Study design: Clinical Trial
Source: Investigational New Drugs
DOI: 10.1007/s10637-013-9972-5
Authors: Yousuke Nakai, Hiroyuki Isayama, Hideaki Ijichi, Takashi Sasaki, Naminatsu Takahara, Yukiko Ito, Saburo Matsubara, Rie Uchino, Hiroshi Yagioka, Toshihiko Arizumi, Tsuyoshi Hamada, Koji Miyabayashi, Suguru Mizuno, Keisuke Yamamoto, Hirofumi Kogure, Natsuyo Yamamoto, Kenji Hirano, Naoki Sasahira, Keisuke Tateishi, Minoru Tada, Kazuhiko Koike
Institutions: The University of Tokyo, Japanese Red Cross Medical Center, Tokyo Metropolitan Police Hospital, Kanto Central Hospital, JR Tokyo General Hospital, Mitsui Memorial Hospital
Language: English

Topic: Pancreatic and Hepatic Oncology Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: gemcitabine, candesartan, advanced pancreatic cancer, renin-angiotensin system blockade, combination chemotherapy, progression-free survival, neutropenia, drug toxicity
SDG: Good health and well-being

Open Access status: green
OpenAlex ID: W2071805383
FWCI: 2.372
Cites: 24
Cited by: 58
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security